Lifeward

Lifeward, formerly ReWalk Robotics, is on a mission to relentlessly drive innovation to change the lives of individuals with physical limitations. The company has evolved from a pioneer in robotic exoskeletons into a diversified rehabilitation technology leader through strategic acquisitions, now offering a continuum-of-care portfolio from clinical to home use. Its core strategy involves expanding market access through payer coverage, leveraging deep clinical evidence, and commercializing its integrated suite of products to capture a significant share of the large and growing neuro-rehabilitation market.

A diversified portfolio of complementary medical device technologies for mobility and rehabilitation, including powered robotic exoskeletons, soft robotic exo-suits, functional electrical stimulation (FES) cycles, and anti-gravity treadmill systems.

Competition is fragmented across product categories, with rivals like Ekso Bionics (exoskeletons) and Hocoma (clinical rehab). Lifeward's key differentiation is its unique, integrated portfolio covering the entire patient rehab journey, which no single competitor currently matches.